HESI LPN
HESI Leadership and Management Test Bank
1. Dr. Shrunk orders intravenous (IV) insulin for Rita, a client with a blood sugar of 563. Nurse AJ administers insulin lispro (Humalog) intravenously (IV). What does the best evaluation of the nurse reveal? Select one that does not apply.
- A. The nurse could have given the insulin subcutaneously.
- B. The nurse did not have to contact the physician.
- C. The nurse should have used regular insulin (Humulin R).
- D. The nurse used the correct insulin.
Correct answer: C
Rationale: The best evaluation of the nurse reveals that she should have used regular insulin (Humulin R) for IV administration. Regular insulin is the only insulin approved for intravenous administration due to its pharmacokinetic properties. Insulin lispro (Humalog) is not suitable for IV use. Choice A is incorrect because giving insulin intravenously is necessary in this case of high blood sugar. Choice B is incorrect because administering a different insulin without consulting the physician is not appropriate. Choice D is incorrect because the nurse used the incorrect insulin, which could pose risks to the client's health.
2. Which of the following is something a new model for health care in the future should include?
- A. Community-centered care
- B. Care that encourages a healthy environment
- C. Accessible care that is affordable for most
- D. A focus on local health concerns
Correct answer: B
Rationale: The correct answer is B because a new model for health care in the future should focus on promoting a healthy environment. This includes initiatives such as green buildings and reducing pollution to improve overall health outcomes. Choice A, community-centered care, is important but not the primary focus when considering the future of healthcare. Choice C, accessible and affordable care, is crucial but does not directly address the need for a healthy environment. Choice D, a focus on local health concerns, is relevant but not as comprehensive as promoting a healthy environment in shaping the future of healthcare.
3. Select a myth or falsehood relating to pain, pain management, and addiction.
- A. Addiction can be accurately predicted.
- B. Withdrawal, drug tolerance, and physical dependence do not indicate addiction.
- C. Pain medications should be avoided in patients with a substance abuse history.
- D. Addiction is signaled by deception and stockpiling by the client.
Correct answer: A
Rationale: The correct answer is A because addiction cannot be accurately predicted. Choices B and C are incorrect. Withdrawal, drug tolerance, and physical dependence are not definitive signs of addiction, and pain medications can be used with patients who have a substance abuse history under careful monitoring. Choice D is incorrect because addiction is not solely signaled by deception and stockpiling; it is a complex condition with various behavioral, physical, and psychological aspects.
4. Your patient has been diagnosed with giant cell arthritis. What medication will this patient most likely be given?
- A. High doses of aspirin
- B. High doses of prednisone
- C. Methotrexate
- D. Albuterol
Correct answer: B
Rationale: High doses of prednisone are commonly prescribed for giant cell arthritis to reduce inflammation. Aspirin is not typically used for this condition. Methotrexate is more commonly used for conditions like rheumatoid arthritis, not giant cell arthritis. Albuterol is a bronchodilator used for respiratory conditions, not for giant cell arthritis.
5. Steven John has type 1 diabetes mellitus and receives insulin. Which laboratory test will the nurse assess?
- A. Potassium
- B. AST (aspartate aminotransferase)
- C. Serum amylase
- D. Sodium
Correct answer: A
Rationale: The correct answer is A: Potassium. Patients with type 1 diabetes receiving insulin are at risk of developing hypokalemia due to insulin's effects on potassium levels. Monitoring potassium levels is crucial to prevent complications such as cardiac arrhythmias. Choices B, C, and D are incorrect because AST, serum amylase, and sodium levels are not directly impacted by insulin therapy in type 1 diabetes and are not the primary concern that needs monitoring in this scenario.
Similar Questions
Access More Features
HESI LPN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All HESI courses Coverage
- 30 days access
HESI LPN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All HESI courses Coverage
- 30 days access